| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-22 |
gene:5552 |
denotes |
Serglycin proteoglycan |
| T1 |
39-55 |
disease:C0026764 |
denotes |
multiple myeloma |
| T2 |
141-150 |
gene:5552 |
denotes |
serglycin |
| T3 |
254-274 |
disease:C0026764 |
denotes |
multiple myeloma (MM |
| T4 |
298-307 |
gene:5552 |
denotes |
serglycin |
| T5 |
384-386 |
disease:C0026764 |
denotes |
MM |
| T6 |
483-492 |
gene:5552 |
denotes |
serglycin |
| T8 |
483-492 |
gene:5552 |
denotes |
serglycin |
| T7 |
590-592 |
disease:C0026764 |
denotes |
MM |
| T9 |
619-651 |
disease:C0085110 |
denotes |
severe combined immunodeficiency |
| T14 |
691-700 |
gene:5552 |
denotes |
serglycin |
| T12 |
732-756 |
gene:3082 |
denotes |
hepatocyte growth factor |
| T10 |
827-836 |
gene:5552 |
denotes |
serglycin |
| T11 |
848-866 |
disease:C1519670 |
denotes |
tumor angiogenesis |
| T13 |
848-866 |
disease:C1519670 |
denotes |
tumor angiogenesis |
| T15 |
848-866 |
disease:C1519670 |
denotes |
tumor angiogenesis |
| T18 |
1002-1024 |
gene:5552 |
denotes |
serglycin proteoglycan |
| T16 |
1090-1099 |
gene:5552 |
denotes |
serglycin |
| T17 |
1118-1120 |
disease:C0026764 |
denotes |
MM |
| T19 |
1118-1120 |
disease:C0026764 |
denotes |
MM |
| T26 |
1262-1271 |
gene:5552 |
denotes |
serglycin |
| T28 |
1262-1271 |
gene:5552 |
denotes |
serglycin |
| T27 |
1299-1301 |
disease:C0026764 |
denotes |
MM |
| T30 |
1316-1320 |
gene:960 |
denotes |
CD44 |
| T22 |
1346-1350 |
gene:960 |
denotes |
CD44 |
| T24 |
1391-1400 |
gene:5552 |
denotes |
serglycin |
| T20 |
1450-1454 |
gene:960 |
denotes |
CD44 |
| T21 |
1480-1487 |
disease:C0026764 |
denotes |
myeloma |
| T23 |
1480-1487 |
disease:C0026764 |
denotes |
myeloma |
| T25 |
1480-1487 |
disease:C0026764 |
denotes |
myeloma |
| T29 |
1480-1487 |
disease:C0026764 |
denotes |
myeloma |
| T31 |
1480-1487 |
disease:C0026764 |
denotes |
myeloma |
| T32 |
1530-1539 |
gene:5552 |
denotes |
serglycin |
| T33 |
1559-1561 |
disease:C0026764 |
denotes |
MM |
| R1 |
T0 |
T1 |
associated_with |
Serglycin proteoglycan,multiple myeloma |
| R10 |
T18 |
T19 |
associated_with |
serglycin proteoglycan,MM |
| R11 |
T20 |
T21 |
associated_with |
CD44,myeloma |
| R12 |
T22 |
T23 |
associated_with |
CD44,myeloma |
| R13 |
T24 |
T25 |
associated_with |
serglycin,myeloma |
| R14 |
T26 |
T27 |
associated_with |
serglycin,MM |
| R15 |
T28 |
T29 |
associated_with |
serglycin,myeloma |
| R16 |
T30 |
T31 |
associated_with |
CD44,myeloma |
| R17 |
T32 |
T33 |
associated_with |
serglycin,MM |
| R2 |
T2 |
T3 |
associated_with |
serglycin,multiple myeloma (MM |
| R3 |
T4 |
T5 |
associated_with |
serglycin,MM |
| R4 |
T6 |
T7 |
associated_with |
serglycin,MM |
| R5 |
T8 |
T9 |
associated_with |
serglycin,severe combined immunodeficiency |
| R6 |
T10 |
T11 |
associated_with |
serglycin,tumor angiogenesis |
| R7 |
T12 |
T13 |
associated_with |
hepatocyte growth factor,tumor angiogenesis |
| R8 |
T14 |
T15 |
associated_with |
serglycin,tumor angiogenesis |
| R9 |
T16 |
T17 |
associated_with |
serglycin,MM |
